PaxVax's Series B Round

PaxVax raised a round of funding on December 04, 2013.

PaxVax, founded in 2007, is a fully integrated specialty vaccine company with a mission to develop, manufacture and commercialize vaccines against infectious diseases in a socially responsible manner.…

Articles about PaxVax's Series B Round: